Insulin eye drops for dry eye disease
Treatments studied
Part of Eyes & vision, Hormones & metabolism clinical trials.
This trial tests whether a new type of eye drop made with insulin can help restore the eye's surface and reduce dry eye symptoms. It may be an option for people with moderate to severe dry eye who haven't improved with other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with dry eye disease, based on specific eye tests (Schirmer test, tear break-up time, and a symptom questionnaire).
- You cannot have an active eye infection or other serious eye surface problem besides dry eye.
- You cannot have had eye surgery in the past 6 months.
- You can be male or female.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether insulin eye drops can safely help dry eye in people who also use eye drops for glaucoma. It may offer a new option if you have both conditions and your eye pressure is stable.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
This study evaluates a new computer-assisted imaging system that uses specialized microscopy to help diagnose dry eye disease. Researchers need both healthy volunteers and people with dry eye symptoms to test how well the system works.
This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.
This study tests a new eye drop treatment made from your own blood serum for severe dry eye that hasn't improved with standard treatments. Researchers will analyze proteins in your tears to understand why this treatment works and who benefits most.
This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.